Chemometric methods for the simultaneous determination of some water-soluble vitamins

Two spectrophotometric methods, derivative and multivariate methods, were applied for the determination of binary, ternary, and quaternary mixtures of the water-soluble vitamins thiamine HCI (I), pyridoxine HCI (II), riboflavin (III), and cyanocobalamin (IV). The first method is divided into first derivative and first derivative of ratio spectra methods, and the second into classical least squares and principal components regression methods. Both methods are based on spectrophotometric measurements of the studied vitamins in 0.1 M HCl solution in the range of 200-500 nm for all components. The linear calibration curves were obtained from 2.5-90 microg/mL, and the correlation coefficients ranged from 0.9991 to 0.9999. These methods were applied for the analysis of the following mixtures: (I) and (II); (I), (II), and (III); (I), (II), and (IV); and (I), (II), (III), and (IV). The described methods were successfully applied for the determination of vitamin combinations in synthetic mixtures and dosage forms from different manufacturers. The recovery ranged from 96.1 +/- 1.2 to 101.2 +/- 1.0% for derivative methods and 97.0 +/- 0.5 to 101.9 +/- 1.3% for multivariate methods. The results of the developed methods were compared with those of reported methods, and gave good accuracy and precision.     

Spectrophotometric determination of certain cephalosporins using molybdophosphoric acid. Part II. Determination of cefadroxil, cefapirin, ceforanide and cefuroxime

The use of molybdophosphoric acid as an oxidising agent for the spectrophotometric determination of four cephalosporin derivatives, viz., cefadroxil monohydrate (I), cefapirin sodium (II), ceforanide L-lysine (III) and cefuroxime sodium (IV), either in the pure form or in pharmaceutical formulations is described. Beer's law is obeyed up to 100 micrograms ml-1 for I, up to 60 micrograms ml-1 for II and IV and up to 80 micrograms ml-1 for III. The molar absorptivities were 4.58 X 10(3), 11.3 X 10(3), 9.8 X 10(3) and 10.9 X 10(3) l mol-1 cm-1 and the Sandell sensitivities were 83.3, 39.3, 53.0 and 41.0 ng cm-2 for I, II, III and IV, respectively. The slopes and intercepts of the equations of the regression line were calculated for each of these drugs with the following correlation coefficients: I, 0.9993; II, 0.9999; III, 1.000; and IV, 0.9999. These antibiotics were determined successfully both in the pure form and in pharmaceutical preparations. The results demonstrated that the proposed procedure is at least as accurate, precise and reproducible as the official methods, while being simpler and less time consuming. A statistical analysis indicated that there was no significant difference between the results obtained by the proposed procedure and those of the official methods.     

Atomic Emission Spectrometric Determination of Antazoline,Hydralazine, Amiloride,Thiamine and Quinine Based on Formation of Ion Associates with Ammonium Reineckate.

Abstract

Ion-associate complexes of Antazoline HC1 (I), Hydralazine HC1 (II), Amiloride HC1 (III), Thiamine HC1 (IV) and Quinine sulphate (V) with ammonium reineckate were precipitated and their solubilities were studied as a function of pH, ionic strength and temperature. Saturated solutions of each ion-associate under the optimum precipitation conditions were prepared and the metal ion-content in the supernatent was determined. The solubility products were thus elucidated at different temperatures. A new accurate and precise method using direct coupled plasma-atomic emission spectrometry for the determination of the investigated drugs in pure solutions and in pharmaceutical preparations is described. The drugs can be determined by the present method in the ranges 0.3-3.0, 0.19-1.96, 0.3-3.0, 0.33-3.37 and 0.78-7.82 mg/25 ml solutions of I, II, III, IV and V, respectively.     

Colorimetric Microdetermination of some Corticosteroid Drugs Using Indophenol as Chromophoric Reagent

Abstract

A simple, rapid and sensitive method for the determination of betamethasone (I), dexamethasone (II) and hydrocortisone (III), either in the pure form or in pharmaceutical formulations is described. The method is based on the development of a brown product with indophenoi in basic aqueous-ethanolic (50% v/v) medium. The optimum reaction conditions for the charge transfer complex formed were assessed. The absorbance measurements were made at 820, 816 and 822 nm for I, II and III respectively. The calibration graph was linear in the range 1-26, 1-32 and 1-35 μg/ml of I, II and III with slopes of 0.028, 0.021 and 0.024, respectively. For more accurate analysis, Ringbom optimum concentration ranges were 2.5-23.0, 3.0-28.5 and 3.0-33.0 μg/ml for I, II and III, respectively. The precision of the procedure was checked by calculating the relative standard deviation of ten replicate determinations on a sample containing 20 μg/ml for each drug and was found to be 1.67, 1.39 and 1.85% for I, II and III, respectively. Many common excepience and common drugs present in their dosage forms do not interfere, and the tolerable levels were evaluated. Results of analysis of pure drugs and their dosage forms by the proposed method are in good agreement with those of the British Pharmacopoeia 1993 procedure.     

Spectrophotometric determination of four macrolide antibiotics in pharmaceutical formulations and biological fluids via binary complex formation with eosin [corrected

A simple, rapid, and sensitive validated spectrophotometric method was developed for the determination of certain macrolide antibiotics namely, erythromycin (I), azithromycin dihydrate (II), clarithromycin (III), and roxithromycin (IV) in bulk powders, pharmaceutical formulations, and spiked biological fluids. The proposed method is based on the formation of a binary complex between each of the studied drugs and eosin Y in aqueous buffered medium. Under the optimum conditions, the binary complexes showed absorption maxima at 542-544 nm. The absorbance of the binary complexes obeyed Beer's law over the concentration range of 1-10 micro/g/mL for II, 2-20 microg/mL for I and IV, and 3-30 microg/mL for III. The mean percentage recoveries were 100.04 +/- 0.83, 99.98 +/- 0.80, 100.17 +/- 0.91, and 99.55 +/- 0.91, with minimum detectable molarities of 2 x 10(-7) for I and II, 4 x 10(-7) for III, and 3 x 10(-7) for IV. The different experimental parameters affecting the development and stability of the colors were studied and optimized. The proposed method was successfully applied to the analysis of the cited drugs in some pharmaceutical formulations. The results obtained were in good agreement with those obtained using the reference methods. The proposed method was further applied to spiked human urine and plasma. A proposal of the reaction pathway is suggested.     

Determination of mercury(II) ion by electrochemical cold vapor generation atomic absorption spectrometry.

A technique for determination of mercury is described; it is based on electrolytic reduction of Hg(II) ion on a graphite cathode, the trapping of mercury vapor and its volatilization into a quartz tube aligned in the optical path of an atomic absorption spectrometer. The electrochemical cell consisted of a graphite cathode and an anode operating with constant direct current for the production of mercury atoms. A pre-activated graphite rod was used as the cathode material. The optimum conditions for electrochemical generation of mercury cold vapor (the electrolysis time and current, the flow rate, the type of electrode and electrolyte) were investigated. The characteristic electrochemical data with chemical cold vapor using NaBH4-acid were compared. The presence of cadmium(II), arsenic(III), antimony(III), selenium(IV), bismuth(III), silver(I), lead(II), lithium(I), sodium(I) and potassium(I) showed interference effects which were eliminated by suitable separation techniques. The calibration curve is linear over the range of 5-90 ng ml(-1) mercury(II). The detection limit is 2 ng ml(-1) of Hg(II) and the RSD is 2.5% (n = 10) for 40 ng ml(-1). The accuracy and recovery of the method were investigated by analyzing spiked tap water and river water.     

Separation and determination of trace amounts of beryllium(II), aluminium(III) and chromium(III) with chromotrope 2C chelates by RP-HPLC

A reversed-phase high-performance liquid chromatographic separation and determination of beryllium(II), aluminium(III) and chromium(III) with chromotrope 2C chelates on a C18-bonded stationary phase is reported. Methanol-water (45:55 v/v) containing 6 x 10(-3)M tetra-n-butylammonium bromide (TBAB) and 2 x 10(-2)M acetate buffer solution (pH 6.0) as mobile phase and with spectrophotometric detection at 530 nm was applied. The method has high sensitivity, the detection limits being 0.2 ppb for beryllium(I), 1 ppb for aluminium(III) and 2 ppb for chromium(III). Under the optimum conditions, most other metal ions did not interfere, e.g. up to 2 mg of Hg(II), Sn(II, IV), Pb(II), Bi(III), Ag(I), Zn(II), Cd(II), Cu(II), 1.5 mg of Fe(II), Co(II), Ni(II), 1.2 mg of Ca(II), Mg(II), Sr(II), Ba(II), 1 mg of Ga(III), In(III), 0.5 mg of Fe(III), 1 mg of Ga(III), In(III), 0.5 mg of Fe(III), 0.4 mg of Th(IV), Zr(IV). The method can be applied to the simultaneous determination of trace amounts of beryllium(II), aluminium(III) and chromium(III), in water, rice, flour and human hair samples.     

Spectrofluorimetric determination of drugs containing active methylene group using N1-methyl nicotinamide chloride as a fluorigenic agent

A spectrofluorimetric method was described for the determination of drugs containing active methylene groups adjacent to carbonyl groups. The method was applied successfully to the determination of three life saving cardiovascular drugs, with narrow therapeutic indices: pentoxifylline (I), propafenone hydrochloride (II) and acebutolol hydrochloride (III), in laboratory-prepared mixtures, in commercial tablets and in plasma samples. The method involved the reaction of each of the tested drugs with N1-methyl nicotinamide chloride (NMNCl) in the presence of alkali, followed by addition of formic acid, where highly fluorescent reaction products were produced. The produced fluorescence were measured quantitatively at 472 nm (lambdaex 352 nm), 409 nm (lambdaex 310 nm) and 451 nm (lambdaex 266 nm) for (I), (II), and (III) respectively. The method was linear over concentration ranges of 10-1000 microg/ml , 0.2-12 microg/ml and 0.08-10 microg/ml in standard solutions for (I), (II), and (III) respectively. In spiked human plasma samples, calibration graphs were linear over concentration ranges of 20-1000 microg/ml, 0.2-15 microg/ml and 0.08-10 microg/ml for (I), (II), and (III) respectively. The method showed good accuracy, specificity and precision in both laboratory-prepared mixtures and spiked human plasma samples. The proposed method is simple, with low instrumentation requirements, suitable for quality control application, bioavailability and bioequivalency studies.     

Spectrofluorimetric determination of guanethidine sulphate, guanoxan sulphate and amiloride hydrochloride in tablets and in biological fluids using 9,10-phenanthraquinone

A highly sensitive spectrofluorimetric method for the determination of some drugs of the monosubstituted guanidine derivatives in laboratory made tablets, in spiked human serum and in urine samples is presented. The method is based on the reaction of guanethidine sulphate (I), guanoxan sulphate (II) and amiloride hydrochloride (III) with 9,10-phenanthraquinone (IV) to give highly fluorescent derivatives. The linearity ranges were found to be 0.06-0.96 mug/ml for (I) and (II) and 0.04-0.28 mug/ml for (III), with relative standard deviation less than 2%. Mean percentage recoveries for tablets were found to be 99.9 +/- 1.3, 100.5 +/- 1.1 and 100.0 +/- 1.6 for I, II and III, respectively. For I and III the results are highly correlated with the B.P. methods. Using the synchronous fluorimetry, differentiation between I and II was possible. Chloroform, dichloromethane and ethyl acetate have been used to extract I, II and III, respectively from serum and urine at basic pH, followed by applying the proposed fluorimetric method. Percentage recoveries were found to be 95.7-102.2%. The limit of detection is 0.04 mug/ml for I and II and 0.02 mug/ml for III.     

Spectrophotometric determination of some drugs for osteoporosis

Three simple, accurate and sensitive spectrophotometric methods are developed for the determination of some new drugs for the treatment of osteoporosis: risedronate sodium (I), alendronate sodium (II) and etidronate disodium (III). The first method is based on the measurement of difference in absorbance (Delta A) of risedronate sodium in 0.01 mol l(-1) hydrochloric and 0.1 mol l(-1) sodium hydroxide at 262 nm. Beer's law is obeyed over a concentration range of 15-150 microg ml(-1) with mean recovery 99.75+/-1.22 and molar absorptivity (epsilon) 1.891 x 10(3). The second method is based on the reaction of the primary amino group of (II) with ninhydrin reagent in methanolic medium in the presence of 0.05 mol l(-1) sodium bicarbonate. The colored product is measured at 568 nm, and the linearity range is found to be 3.75-45 microg ml(-1) with mean recovery 99.77+/-0.73 and epsilon 9.425 x 10(3). The third method is based on oxidation of the three mentioned drugs with ceric (IV) sulphate in 0.5 mol l(-1) sulphuric acid at room temperature and subsequent measurement of the excess unreacted cerium (IV) sulphate at 320 nm. The method obeyed Beer's law over a concentration range of 2-24 microg ml(-1) for the three drugs with mean recovery 99.79+/-1.16, 99.73+/-1.38 and 99.86+/-1.13 and epsilon 14.427 x 10(3), 13.813 x 10(3) and 14.000 x 10(3) for drugs I, II, III respectively. The proposed methods were successfully applied for the determination of the studied drugs in bulk powder and in pharmaceutical formulations. The results were found to agree statistically with those obtained the reported methods. Furthermore, the methods were validated according to USP regulations and also assessed by applying the standard addition technique.     

Determination of malotilate and its metabolites in plasma and urine

A method for the determination of malotilate (I), the corresponding monocarboxylic acid (II) and its decarboxylated product (III) in plasma is described. Plasma was extracted with chloroform spiked with internal standard. The residue, dissolved in methanol, was chromatographed on a reversed-phase column with a mobile phase of 60% acetonitrile and 1% acetic acid in water. The sensitivity limit for I, II and III was 50, 25 and 100 ng/ml of plasma, respectively. Compound I in the same plasma extract was also analysed by gas chromatography--electron-impact mass spectrometry. The base peaks m/z 160 for I and m/z 162 for internal standard (IV) were monitored; the sensitivity limit for I was 2.5 ng/ml of plasma. The determination of the metabolites of I, II and its conjugate (V), and isopropyl-hydrogen malonate (VI) in urine by high-performance liquid chromatography is also described. The limit of quantification for VI was 2.0 micrograms/ml, and the overall coefficient of variation of VI was 4.7%. The limit of quantification for II in urine was 0.5 micrograms/ml and that for V was 1.0 micrograms/ml as total II (II + V). The overall precision of the method was satisfactory. The method was used to determine plasma and urine concentrations in four dogs orally dosed with 100, 200 or 400 mg of malotilate.     

Analytical applications of m- and p-phenylene-di(1-tetrazoline-5-thione) Gravimetric determination of ruthenium(lll) in presence of large amounts of rhodium (III)

A simple and rapid method is described for the gravimetric determination of ruthenium(III) with two new isomeric reagents, m-and p-phenylene-di(1-tetrazoline-5-thione). Solutions containing milligram amounts of ruthenium(III)on treatment with the acetone or alcohol solutions of the reagents at pH 5.5-7.0 give a quantitative yield of an intensely green insoluble 1:1 complex which can be easily filtered off and dried at 110-115 degrees . Amounts of ruthenium down to 0.5 mg can be determined with fairly good accuracy and precision. Even large amounts of rhodium do not cause any interference. The following cations interfere: Pd(II), Pt(IV), Au(III), Ir(IV), Bi, Fe(III), Cu(II), Hg(I), Hg(II), Pb, Cd, T1(I) and Ag.     

Solvent extraction separation of tin (IV) with 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester (PC-88A)

Solvent extraction of tin(IV) from hydrochloric acid media was carried out with 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester (PC-88A) in toluene. Tin(IV) was quantitatively extracted with 2.5x10(-2) M PC-88A in toluene from 0.1-0.3 M HCl when equilibrated for 5 min. Tin(IV) from the organic phase was stripped with 4 M HCl and determined spectrophotometrically by both the morin and pyrocatechol violet method. The nature of the extracted species was determined from the log-log plots. Various other diluents such as xylene, hexane and cyclohexane also gave quantitative extraction of tin. The metal loading capacity of the reagent was found to be 0-15 ppm of tin(IV). The extraction of tin(IV) was carried out in the presence of various ions to ascertain the tolerance limit of individual ions. Tin(IV) was successfully separated from commonly associated metal ions such as antimony(III), bismuth(III), lead(II), thallium(I), copper(II), nickel(II), etc. The method was extended for determination of tin in real samples.     

Exthaktiv-Spekthophotometrische Bestimmung Von Rh(III) in Gegenwart Der Platinmetalle,Gold Und Silber Unter Anwendung Von 1-(2-Pyridylazo)-2-Naphthol

Abstract

A spectrophotometric method is described for the determination of 25–150μ;g of rhodium (III) using 1-(2-pyridylazo)-2-naphthol. One milligram of Ir(III) or Ir(IV), 200μ;g Ru(IV), 400μ;g Os(IV), 350μ;g Pt(IV), 5 mg Ag(I), and 100μ;g Au(III) do not interfere. Larger amounts of silver and gold are removed as AgCl and, after reduction with ascorbic acid, Au metal. A modification of the method permits the successive determination of 4–100μ;g of Hh(III) and 50–500μ;g of Pd(II) in a single sample.     

Spectrophotometric determination of some antihistaminic drugs using 7,7,8,8-tetracyanoquinodimethane (TCNQ)

A simple and sensitive spectrophotometric method is suggested for analysis of 3 antihistaminic drugs, acrivastine (I), mequitazine (II), and dimethindene maleate (III). The method is based on reaction of the drugs with 7,7,8,8-tetracyanoquinodimethane (TCNQ) in acetonitrile to form highly stable colored products that are measured at 750, 766, and 844 nm for I and II, and 480 and 618 nm for III. Beer's law is obeyed in the ranges of 5-60 microg/mL for 1, 5-50 microg/mL for II, and 10-70 microg/mL for III. The optimum assay conditions and their applicability to the determination of the cited drugs in pharmaceutical formulations are described. The method is statistically analyzed as compared with the European Pharmacopoeia (2001) method for the analysis of dimethindene maleate and reference methods for acrivastine and mequitazine drugs revealing good accuracy and precision.     

Sequential speciation of selenium by flow injection cathodic stripping voltammetry

A semi-automatic continuous method for the determination of Se(IV) based on flow-injection cathodic stripping voltammetry (FICSV) is reported. The flow injection approach incorporates a thin mercury film on glassy carbon as the working electrode, on which Se(IV) is deposited at an applied potential of 0.0 V. A cathodic scan (from 0.0 to –0.9 V) is applied and the Se is stripped at –0.54 V, providing a current intensity proportional to the Se(IV) concentration in the sample. This method features a linear determination range between 0.5 and 30 ng/ml (r²=0.998, RSD=3.6%). The non-interference levels (foreign species to analyte ratio) are 2.5:1 for Cu(II), 7.5:1 for Pb(II), 35:1 for Cd(II), 250:1 for Zn(II) and 500:1 for Fe(III). After developing the method for Se(IV), the speciation of this element has been performed by sequential injection of the dissolved sample into a carrier which may or may not have been previously reduced off-line thus determining the sum (Se(IV)+Se(VI)) or only Se(IV), respectively. The method has been applied to selenium speciation in water samples.     

The surfactant sensitized analytical reaction of cerium(IV) with some triphenylformazan derivatives

Cationic surfactant, cetylpyridinium bromide (CPB), sensitizes the colour reaction of cerium(IV) with 1,3-o-hydroxyphenyl-5-phenylformazan(I), 1-m-hydroxyphenyl-3-o-hydroxyphenyl-5-phenylformazan(II) and 1-m-carboxyphenyl-3-o-hydroxyphenyl-5-phenylformazan(III). The formation of a soluble ternary complex of stoichiometric ratio 1:1:1 (Ce(IV)-R-CPB) is responsible for the observed enhancement in the molar absorptivity and Sandell sensitivity of the formed complex, when a surfactant is present. The ternary complex exhibits absorption maxima at 596, 571 and 607 nm (epsilon=6.05 x 10(4), 6.28 x 10(4) and 8.06 x 10(4)L mol(-1)cm(-1)) using triphenylformazan derivatives I, II and III, respectively. Beer's law is obeyed between 0.15 and 2.5 microg ml(-1), whereas, optimum concentration range applying Ringbom method is in the range 0.30-2.25 microg ml(-1). Conditional formation constants in the presence and absence of CPB for Ce(IV) complexes have been calculated. The proposed method has been successfully applied to the analysis of magnesium-base cerium alloys and synthetic mixtures corresponding to various cerium alloys.     

Preconcentration of Nickel(II) in White Wine Using Quinoxaline-2,3-dithiol and a Finely Divided Anion-Exchange Resin for the Determination by Solid-Phase Spectrophotometry

A simple and sensitive method for the determination of trace amounts of nickel(II) is described. The method is based on the adsorptive enrichment of nickel(II) as the complex with quinoxaline-2,3-dithiol using a finely divided anion-exchange resin, collection of the resin on a membrane filter by filtration, and direct measurement of the absorbance of the resultant circular thin layer by reflective spectrophotometry at 605 nm. In the presence of interfering cations such as copper(II) and cobalt(II) a sample solution is first filtered, after the addition of ammonium thiocyanate and Zephiramine, to extract these cations onto a membrane filter as the ion-pair precipitate formed between the metal-thiocyanate complex anions and Zephiramine cations, then nickel(II) in the filtrate is determined. Interferences from iron(III), silver(I), bismuth(III), cadmium(II), mercury(II), indium(III), palladium(II), platinum(IV), tin(IV), and zinc(II) can also be eliminated. The proposed method was applied to the determination of nickel in white wine. The concentrations of nickel found in 5-ml aliquots of 10 different wine samples were in the range 16.1-68.0 ng ml⁻¹.     

Spectrophotometric assay of cephalosporins in pharmaceutical products,using chromotrope 2B and chromotrope 2R

A simple, rapid and sensitive Spectrophotometric method is proposed for the determination of cephadroxil (I), cephalexin (II) and cephradine (III). The method is based on ion-pair complex formation between these derivatives and Chromotrope 2B (C2B) or Chromotrope 2R (C2R), to give a highly coloured radical anion. The coloured products are quantified spectrophotometrically at 542 and 564 nm for C2B and C2R, respectively. The optimization of the experimental conditions is described. The method has been used for the determination of 0.4–15, 0.4–14 and 0.4–18 g/ml of drugs I, II and III, respectively. The accuracy of the method is indicated by the excellent recovery (100.0±1.7%) and the precision is supported by the low relative standard deviations 1.5%. The sensitivity of the method is discussed and the results are compared with the official method. The interference from common degradation products and excipients was also studied. The proposed method was applied successfully to the determination of the different cephalosporins in dosage forms, with good precision and accuracy. The results were compared with those given by the official B.P. 1993 method.